Articles in Home | Health & Fitness | HIV - AIDS

  • PAVE 100 HIV vaccine trial too risky in current state  By : Scientist Live
    In the fall of 2007, research in the field of HIV vaccination was moving confidently towards larger trials involving a broader sweep of individuals. Two vaccines in particular stood at the forefront - the Merck STEP vaccine and the PAVE 100 - and the scientific community was generally optimistic about their potential.
  • What HIV needs  By : Scientist Live
    The Salk Institute for Biological Studies and Burnham Institute for Medical Research today announced 295 host cell factors that are involved in human immunodeficiency virus (HIV) infection
 
 
Sign Up for a free account or learn more.
 
Print This Article
Post Comment
Add To Favorites
Email to Friends
Ezine Ready
 
Home
Submit Articles
Member Login
Top Authors
Submission Guidelines
Ezine Notifications
Article RSS Feeds
 
New Stuff
About Us
Forum
Link to Us
Contact Us
Privacy Policy
Terms of Service
Top 5 Authors

newagephilosopher(55)

Stephen Jones(34)

Amanda Somers(34)

Enrique Helmbrecht(33)

ginfop5(30)
 
 
 
© 2007 Submit Article for free.com All Rights Reserved.
Use of our service is protected by our Privacy Policy and Terms of Service
Site Map